VICARIOUS SURGICAL INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
VICARIOUS SURGICAL INC. (RBOT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $42.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-03-09
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $12.00K.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-06-30 was $23.00K.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-03-31 was $7.00K, a 22.22% decline year-over-year.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $42.00K, a 320.00% increase from fiscal 2024.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $10.00K, a 99.44% decline from fiscal 2023.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $1.77M, a 82.38% decline from fiscal 2022.
- VICARIOUS SURGICAL INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $10.07M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $12.00K derived: sum of 2 quarters · filed 2026-03-09 | $35.00K derived: sum of 3 quarters · filed 2026-03-09 | $42.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $35.00K derived: sum of 2 quarters · filed 2025-11-12 | $42.00K 10-Q · filed 2025-11-12 | $43.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $30.00K 10-Q · filed 2025-08-12 | $31.00K derived: sum of 3 quarters · filed 2026-03-09 | $31.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-12 | $8.00K derived: sum of 2 quarters · filed 2026-03-09 | $8.00K derived: sum of 3 quarters · filed 2026-03-09 | $8.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.00K derived: sum of 3 quarters · filed 2026-03-09 | $10.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $9.00K 10-Q · filed 2025-11-12 | $35.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $9.00K 10-Q · filed 2025-08-12 | $35.00K derived: sum of 3 quarters · filed 2025-08-12 | $84.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-12 | $35.00K derived: sum of 2 quarters · filed 2025-05-12 | $84.00K derived: sum of 3 quarters · filed 2025-05-12 | $1.03M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $75.00K derived: sum of 2 quarters · filed 2025-03-17 | $1.02M derived: sum of 3 quarters · filed 2025-03-17 | $1.77M 10-K · filed 2025-03-17 |
| 2023-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $991.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.75M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $942.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.70M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $757.00K 10-Q · filed 2024-04-29 | |||
| 2022-12-31 | $10.07M 10-K · filed 2024-03-04 | |||
| 2021-12-31 | $4.00 10-K · filed 2022-03-31 |